Currently out of the existing stock ratings of Esther Hong, 17 are a BUY (77.27%), 5 are a HOLD (22.73%).

Esther Hong

Work Performance Price Targets & Ratings Chart

Analyst Esther Hong, carries an average stock price target met ratio of 60% that have a potential upside of 33.41% achieved within 186 days. Previously, Esther Hong worked at LOOP CAPITAL, JANNEY, BERENBERG.

Esther Hong’s has documented 45 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BNOX, Bionomics Ltd ADR at 09-Mar-2023.

Wall Street Analyst Esther Hong

Analyst best performing recommendations are on ATHA (ATHIRA PHARMA ).
The best stock recommendation documented was for ATHA (ATHIRA PHARMA ) at 4/21/2022. The price target of $33 was fulfilled within 62 days with a profit of $84.8 (71.99%) receiving and performance score of 11.61.

Average potential price target upside

of $73.29 (73.51%) on BNOX (BIONOMICS LTD ADR).
of $45.28 (80.07%) on AXSM (AXSOME THERAPEUTICS).
of $1.42 (6.71%) on ACAD (ACADIA PHARMACEUTICALS).

ALDX Aldeyra The CNCE Concert Pharmaceuticals SPRO Spero Therapeutics ACAD ACADIA Pharmaceuticals AXSM Axsome Therapeutics BNOX Bionomics Ltd ADR CMPS Compass Pathways Plc ATHA Athira Pharma BN Brookfield Corp CNC Centene Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Matthew Caufield (HC WAINWRIGHT)